#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Factor IX deficiency Hypochromic anaemia Cardiac sarcoidosis Bronchiolitis Transitional cell cancer of the renal pelvis and ureter Diffuse large B-cell lymphoma refractory Endometrial adenocarcinoma Anaplastic large cell lymphoma T- and null-cell types Complex regional pain syndrome Colon cancer Myocarditis Chronic lymphocytic leukaemia Exudative retinopathy Prostate cancer Hypereosinophilic syndrome More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Trials in Disease Hereditary angioedema – Trials in Disease Paraneoplastic neurological syndrome – Life with Disease Alexander disease – Treatment Uterine leiomyosarcoma – Trials in Disease Mitochondrial myopathy Amyotrophic lateral sclerosis – Trials in Disease Sarcoidosis – Treatment Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Angiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ertugliflozin Zagociguat PROMESTRIENE Citric Acid Bi 1291583 ANXV Ciclosporin Atrasentan Hydrochloride Fenebrutinib Thymalfasin Cetuximab CIRTUVIVINT Ro7790121 Tomligisiran Thiamine Ziltivekimab Octreotide Acetate AVTX-009 TETRODOTOXIN Perflutren More therapies…

    Learn about Your Condition

    Dermatitis atopic Arteriovenous malformation Carotid artery stenosis Metachromatic leukodystrophy Malignant melanoma Uveal melanoma Asplenia Pemphigoid Major depression Lung transplant rejection Abdominal pain Acquired haemophilia Connective tissue disorder Endometrial cancer stage IV Polymyositis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Capecitabine
    • Pembrolizumab
    • Sacituzumab Govitecan
    Belgium France Germany Ireland Italy Spain

  • Study of petosemtamab alone or with drug combination for patients with advanced colorectal cancer and other solid tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    • Neoplasm malignant
    Investigated Drugs:
    • Petosemtamab
    • Calcium Folinate
    • Fluorouracil
    Belgium France Italy The Netherlands Spain

  • Study on Organ Preservation in Kidney, Liver, and Pancreas Transplants Using Custodiol-N Solution Compared to a Drug Combination for Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Liver transplant
    • Renal transplant
    Investigated Drugs:
    • Aspartic Acid
    • Calcium
    • Chloride Ion
    Austria

  • Study on Citalopram for Patients with Reflux Hypersensitivity or Functional Heartburn Not Fully Helped by Proton Pump Inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Gastrooesophageal reflux disease
    Investigated Drugs:
    • Citalopram
    Belgium

  • Study of SAR445877 and Cetuximab for Adults with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Kd050
    • Bevacizumab
    • Cetuximab
    The Netherlands Spain

  • Study on Antibiotic Treatment for Hip and Knee Joint Infections Using Linezolid, Fusidic Acid, and Rifampicin

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Bromhexine Hydrochloride
    • Clindamycin Hydrochloride
    • Fusidic Acid
    Sweden
Previous Page
1 … 622 623 624 625 626 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!